Tudor Investment Corp Portfolio holdings
AUM
$13.2B
1-Year Return
6.99%
This Quarter Return
+7.72%
1 Year Return
+6.99%
3 Year Return
+37.99%
5 Year Return
+86.9%
10 Year Return
+285.99%
AUM
$4.07B
AUM Growth
-$10.3M
(-0.25%)
Cap. Flow
-$217M
Cap. Flow
% of AUM
-5.34%
Top 10 Holdings %
Top 10 Hldgs %
9.81%
Holding
2,182
New
441
Increased
490
Reduced
464
Closed
484
Top Buys
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$73.8M |
| 2 |
COUP
Coupa Software Incorporated
COUP
|
+$42.4M |
| 3 |
COWN
Cowen Inc. Class A Common Stock
COWN
|
+$27.8M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$19.2M |
| 5 |
POSH
Poshmark, Inc. Class A Common Stock
POSH
|
+$18.7M |
Top Sells
| 1 |
Y
Alleghany Corporation
Y
|
+$93.4M |
| 2 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$71.8M |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
+$42.9M |
| 4 |
ZEN
ZENDESK INC
ZEN
|
+$42.3M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$41.6M |
Sector Composition
| 1 | Technology | 19.83% |
| 2 | Financials | 14.55% |
| 3 | Industrials | 13.3% |
| 4 | Healthcare | 12.71% |
| 5 | Consumer Discretionary | 10.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SRG
1301
Seritage Growth Properties
SRG
$251M
| $257K | 0.01% |
+21,742
| New | +$257K |
|
1302
RELX
RELX
$82.4B
| $255K | 0.01% |
9,190
-16,610
| -64% | -$461K |
|
1303
Digimarc
DMRC
$203M
| $254K | 0.01% |
13,753
-10,251
| -43% | -$189K |
|
1304
Heritage Commerce
HTBK
$630M
| $252K | 0.01% |
19,360
-17,316
| -47% | -$225K |
|
1305
Regenxbio
RGNX
$483M
| $252K | 0.01% |
11,110
-2,791
| -20% | -$63.3K |
|
1306
Revolve Group
RVLV
$1.67B
| $252K | 0.01% |
11,307
-43,227
| -79% | -$963K |
|
1307
CTS Corp
CTS
$1.22B
| $251K | 0.01% |
+6,373
| New | +$251K |
|
1308
Repare Therapeutics
RPTX
$75.6M
| $251K | 0.01% |
+17,034
| New | +$251K |
|
1309
Brady Corp
BRC
$3.69B
| $249K | ﹤0.01% |
+5,280
| New | +$249K |
|
1310
Astec Industries
ASTE
$1.06B
| $246K | ﹤0.01% |
6,043
-10,577
| -64% | -$431K |
|
1311
Geron
GERN
$823M
| $246K | ﹤0.01% |
101,782
-9,843
| -9% | -$23.8K |
|
1312
Novanta
NOVT
$4.14B
| $246K | ﹤0.01% |
+1,813
| New | +$246K |
|
1313
EyePoint Pharmaceuticals
EYPT
$934M
| $245K | ﹤0.01% |
70,096
+7,337
| +12% | +$25.6K |
|
1314
Canadian National Railway
CNI
$57.7B
| $244K | ﹤0.01% |
+2,053
| New | +$244K |
|
1315
OptimizeRx
OPRX
$326M
| $244K | ﹤0.01% |
14,539
-19,340
| -57% | -$325K |
|
|
ENFN
1316
DELISTED
Enfusion, Inc.
ENFN
| $244K | ﹤0.01% |
+25,256
| New | +$244K |
|
1317
Nurix Therapeutics
NRIX
$684M
| $243K | ﹤0.01% |
22,162
-35
| -0.2% | -$384 |
|
1318
Ameris Bancorp
ABCB
$5.07B
| $242K | ﹤0.01% |
5,130
-10,153
| -66% | -$479K |
|
1319
EverCommerce
EVCM
$2.06B
| $240K | ﹤0.01% |
+32,205
| New | +$240K |
|
1320
iShares US Transportation ETF
IYT
$604M
| $239K | ﹤0.01% |
4,468
-29,852
| -87% | -$1.6M |
|
|
WEBR
1321
DELISTED
Weber Inc.
WEBR
| $238K | ﹤0.01% |
+29,602
| New | +$238K |
|
|
PLL
1322
DELISTED
Piedmont Lithium
PLL
| $236K | ﹤0.01% |
+5,368
| New | +$236K |
|
1323
Revvity
RVTY
$9.58B
| $236K | ﹤0.01% |
+1,683
| New | +$236K |
|
1324
Equity Bancshares
EQBK
$809M
| $235K | ﹤0.01% |
+7,191
| New | +$235K |
|
1325
LeMaitre Vascular
LMAT
$2.1B
| $235K | ﹤0.01% |
5,099
-12,056
| -70% | -$556K |
|